Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies
Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies
Background
Claudin-low breast carcinoma represents 19% of all breast cancer cases and is characterized by an aggressive progression with metastatic nature and high rates of relapse. Due to a lack of known specific molecular biomarkers for this breast cancer subtype, there are no targeted therapies available, which results in the worst prognosis of all breast cancer subtypes. Hence, the identification of novel biomarkers for this type of breast cancer is highly relevant for an early diagnosis. Additionally, claudin-low breast carcinoma peptide ligands can be used to design powerful drug delivery systems that specifically target this type of breast cancer.
Methods
In this work, we propose the identification of peptides for the specific recognition of MDA-MB-231, a cell line representative of claudin-low breast cancers, using phage display (both conventional panning and BRASIL). Binding assays, such as phage forming units and ELISA, were performed to select the most interesting peptides (i.e., specific to the target cells) and bioinformatics approaches were applied to putatively identify the biomarkers to which these peptides bind.
Results
Two peptides were selected using this methodology specifically targeting MDA-MB-231 cells, as demonstrated by a 4 to 9 log higher affinity as compared to control cells. The use of bioinformatics approaches provided relevant insights into possible cell surface targets for each peptide identified.
Conclusions
The peptides herein identified may contribute to an earlier detection of claudin-low breast carcinomas and possibly to develop more individualized therapies.
881-894
Luzia De Nobrega, Franklin
6532795d-88a4-4f05-9b26-6af5b8f21a0d
Ferreira, Débora
fd696bdf-78db-4dcd-b3f1-004e1c120d71
Martins, Ivone M
dda211c7-4196-4657-9375-a44699ba0b6b
Suarez-Diez, M
c9e36214-947d-44f4-b0e1-90a44473be77
Azeredo, Joana
0e6aef86-c71c-4b48-a071-0c7cc93fe042
Kluskens, Leon D
12623693-d537-4522-8369-3cbe51f59ee3
Rodrigues, Lígia R
c3baa7f9-8316-4b95-b461-2b79823d862a
14 November 2016
Luzia De Nobrega, Franklin
6532795d-88a4-4f05-9b26-6af5b8f21a0d
Ferreira, Débora
fd696bdf-78db-4dcd-b3f1-004e1c120d71
Martins, Ivone M
dda211c7-4196-4657-9375-a44699ba0b6b
Suarez-Diez, M
c9e36214-947d-44f4-b0e1-90a44473be77
Azeredo, Joana
0e6aef86-c71c-4b48-a071-0c7cc93fe042
Kluskens, Leon D
12623693-d537-4522-8369-3cbe51f59ee3
Rodrigues, Lígia R
c3baa7f9-8316-4b95-b461-2b79823d862a
Luzia De Nobrega, Franklin, Ferreira, Débora, Martins, Ivone M, Suarez-Diez, M, Azeredo, Joana, Kluskens, Leon D and Rodrigues, Lígia R
(2016)
Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies.
BMC cancer, 16 (1), , [881].
(doi:10.1186/s12885-016-2937-2).
Abstract
Background
Claudin-low breast carcinoma represents 19% of all breast cancer cases and is characterized by an aggressive progression with metastatic nature and high rates of relapse. Due to a lack of known specific molecular biomarkers for this breast cancer subtype, there are no targeted therapies available, which results in the worst prognosis of all breast cancer subtypes. Hence, the identification of novel biomarkers for this type of breast cancer is highly relevant for an early diagnosis. Additionally, claudin-low breast carcinoma peptide ligands can be used to design powerful drug delivery systems that specifically target this type of breast cancer.
Methods
In this work, we propose the identification of peptides for the specific recognition of MDA-MB-231, a cell line representative of claudin-low breast cancers, using phage display (both conventional panning and BRASIL). Binding assays, such as phage forming units and ELISA, were performed to select the most interesting peptides (i.e., specific to the target cells) and bioinformatics approaches were applied to putatively identify the biomarkers to which these peptides bind.
Results
Two peptides were selected using this methodology specifically targeting MDA-MB-231 cells, as demonstrated by a 4 to 9 log higher affinity as compared to control cells. The use of bioinformatics approaches provided relevant insights into possible cell surface targets for each peptide identified.
Conclusions
The peptides herein identified may contribute to an earlier detection of claudin-low breast carcinomas and possibly to develop more individualized therapies.
This record has no associated files available for download.
More information
Accepted/In Press date: 25 October 2016
Published date: 14 November 2016
Identifiers
Local EPrints ID: 443073
URI: http://eprints.soton.ac.uk/id/eprint/443073
ISSN: 1471-2407
PURE UUID: 6f2d3ac7-bb9a-4866-8540-a86abf03639d
Catalogue record
Date deposited: 10 Aug 2020 16:30
Last modified: 17 Mar 2024 04:02
Export record
Altmetrics
Contributors
Author:
Débora Ferreira
Author:
Ivone M Martins
Author:
M Suarez-Diez
Author:
Joana Azeredo
Author:
Leon D Kluskens
Author:
Lígia R Rodrigues
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics